Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Indraprastha Medical Corporation Ltd. Share Price
Day's Range
Day's Range
Low
₹419.50
High
₹440.60
Price Summary
| Previous Close | ₹436.90 |
|---|---|
| Day's Range | ₹419.50 - ₹440.60 |
| Open | ₹428.45 |
| 52 Week Range | ₹342.00 - ₹640.85 |
| Volume | 5,52,990 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 2,397.74 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 1.03 |
| Price/Earning (TTM) | 21.88 |
| TTM EPS (₹) | 19.95 |
| P/E Ratio | 21.98 |
| Book Value(₹) | 5.72 |
| PAT Margin (%) | 11.87 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 41.43 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 3249.3 | 12447.0 |
| Expenses | N/A | N/A |
| PBT | 445.3 | 1661.1 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 328.1 | 1239.6 |
About Indraprastha Medical Corporation Ltd.
| Founded | 1988 |
|---|---|
| Managing Director | Shivakumar Pattabhiraman |
| NSE Symbol | INDRAMEDCO |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,49,251.48 | 1,872.40 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,242.24 | 6,728.70 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,52,951.96 | 4,512.30 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,191.66 | 8,085.00 | 6,696.50 - 6,696.50 |
| Dr. Reddy's Laboratories Ltd. | 1,06,811.05 | 1,282.15 | 1,143.90 - 1,143.90 |
| Cipla Ltd. | 1,05,391.40 | 1,304.70 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,02,674.68 | 2,249.70 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,01,937.63 | 2,456.00 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,01,003.24 | 1,040.85 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 96,261.37 | 956.65 | 835.50 - 835.50 |
No Records Found
Latest News
Indraprastha Medical Corporation informs about disclosure on non-applicability of large Corporate
Indraprastha Medical Corporation informs about closure of trading window
Pursuant to the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading, Indraprastha Medical Corporation has informed that the trading window of the Company will remain closed (for the purpose of consideration of audited financial results for the quarter and year ending on 31st March, 2026, along with other matters for which trading window is required to be closed) from Wednesday, 1st April, 2026, till 48 hours after the announcement/ declaration of the audited financial results. During the period of Closure of the Trading Window, all directors, Designated Employees, Insiders and their immediate relatives will not enter into any transaction involving the securities of the Company. The Trading window will open 48 hours after the announcement/declaration of the audited financial results for the quarter and year ending on 31st March, 2026, to the stock exchanges. The date of the Board Meeting to consider and approve the audited financial results for the quarter and year ending 31st March, 2026, be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
Indraprastha Medical Corporation informs about scrutinizers report
Solara Active Pharma Sciences informs about analyst meet
Solara Active Pharma Sciences has informed that the Company has scheduled a conference call with analysts/ investors to discuss Company’s audited financial results for the quarter and financial year ended March 31, 2026 on Friday, May 15, 2026 at 03:00 pm (IST). Analysts / Investors Conference Call details are enclosed. Further, the above information will also be available on the website of the Company: https://solara.co.in/investor-relations/schedule-of-investors-meet-and-investors-presentations.
The above information is a part of company’s filings submitted to BSE.
Sai Life Sciences informs about earnings conference call
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Indraprastha Medical Corporation Ltd. is ₹436.90 as of 2026-05-11.
The market capitalisation of Indraprastha Medical Corporation Ltd. is ₹4,002.90 as of 2026-05-11.
The 1-year return of Indraprastha Medical Corporation Ltd. is 0.00% as of 2026-05-11.
The P/E ratio of Indraprastha Medical Corporation Ltd. is 21.98 as of 2026-05-12.
The 52-week high and low of Indraprastha Medical Corporation Ltd. are ₹640.85 and ₹342.00, respectively, as of 2026-05-11.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
